Latest News

  • Australian Company Pursues World-First Ingestible Gas-Sensing Capsule

    Diagnostics World News | Despite the explosion of interest in the microbiome and the array of companies examining its composition, there remains an unmet clinical need for measuring microbiome function. And it’s a void Atmo Biosciences is looking to fill.

    Jan 14, 2020
  • New Technologies Can Step Up Fight Against Antimicrobial Resistance and Sepsis

    Diagnostics World News Contributed Commentary | The need for more accurate diagnostics for acute infections is clear, and several novel and promising diagnostic technologies have come to market recently, with more in the pipeline.

    Jan 10, 2020
  • Top 10 Stories Of 2019: Autism Blood Test Becomes Reality, Liquid Biopsy Developments, And More

    Diagnostics World News | As we head into 2020, we at Diagnostics World News would like to take a moment and reflect on the groundbreaking achievements from this past year. In that spirit, here are the top 10 stories of 2019, ranked in order of popularity.

    Jan 9, 2020
  • Caris Launches First Ever Molecular AI Product: A Clinical Genomic Profiling Similarity Score

    Diagnostics World News | Caris announced the launch of its MI GPS (Genomic Profiling Similarity) Score, an AI-driven tumor type biology similarity score that uses a machine learning algorithm to compare molecular characteristics of a patient’s tumor against Caris’ database.

    Jan 8, 2020
  • Follow the Money: New Life Sciences Investment Firm, ArcherDX, ChromaCode, And More

    Diagnostics World News | Several molecular diagnostics companies receive funding to advance PCR platforms and companion diagnostics. TwinStrand Biosciences closes a Series A fund to create a new genomic sequencing technology. Perceptive Advisors launches a new venture capital fund for early-stage life sciences companies, and more.

    Jan 7, 2020
  • New Slides For Fluorescent Diagnostics

    Diagnostics World News | Last month NANOPEC Technologies announced MetaFluorex, a new class of proprietary nano-structured ceramic films, that the company says have shown to enhance fluorescent signals by factors as large as 100 times, depending on the assay, when compared to the glass slides currently used for in vitro diagnostic testing.

    Jan 3, 2020
  • Bacterial, Viral, or Neither? Host Response Test Has Answers

    Diagnostics World News | A Duke University spin-out company is putting the last touches on a host response bacterial-viral test entering the final leg of the Antimicrobial Resistance (AMR) Diagnostic Challenge of the National Institutes of Health Division of Program Coordination, Planning, and Strategic Initiatives.

    Jan 2, 2020
  • Charles River, Takeda, Veracyte, and More: News From December 2019

    Diagnostics World News | December featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Charles River, Takeda, Veracyte, and more.

    Dec 23, 2019
  • Proteins Could Be Basis Of Comprehensive ‘Liquid Health Check’

    Diagnostics World News | Researchers have known for a very long time that proteins circulating in human blood can, like the proverbial canary in the coal mine, be signals of health and disease risk. Until recently, the association has been exploited only in one-at-a-time experiments, usually with mass spectrometry technology.

    Dec 19, 2019
  • Building Diagnostics With Data In Mind

    Diagnostics World News | Ativa’s diagnostic workstation claims to be the only point-of-care system using a big-data approach to blood and urine testing to provide results on the major test panels used today to diagnose patients, and advanced diagnostic tests that gives deeper, more concise, disease information. If that sounds to you too good to be true, Ativa’s co-founder and CEO, is quick to point the company’s secrets to success: a team approach with solid partnerships, AI-driven analysis, and a seismic shift in the way data is collected for diagnostic testing.

    Dec 18, 2019
  • Critical Biomarkers Emerging From ‘Not-So-Sexy’ Science

    Diagnostics World News | The Foundation for the National Institutes of Health is laser-focused on potentially transformative drug development tools that require group devotion to “not-so-sexy” science.

    Dec 17, 2019
  • QuantuMDx, Ontera Collaborate On Sepsis Detection

    Diagnostics World News Brief | Ontera and QuantuMDx announced a collaboration this week to create a next-generation solution for blood stream infection and drug resistance detection. The technology will be based on QuantuMDx’s rapid cell/sample preparation technology, Capture-XT, and Ontera’s powerful nanopore biosensor, currently used in their SAM and DUO Nano platforms.

    Dec 12, 2019
  • Charles River Partners with Bit Bio, Increasing Portfolio of Translational Drug Discovery Technologies

    Diagnostics World News Brief | Charles River announced that it has entered into an exclusive Discovery and Safety Services partnership with Bit Bio, a company that offers consistent and efficient reprogramming of human cells for use in research, drug discovery, and cell therapies.

    Dec 11, 2019
  • The Case For Lung Cancer Screening: Lessons from Lahey Health

    Diagnostics World News | Most patients, as well as most primary care physicians, consider lung cancer to be highly lethal. That’s because early-stage disease tends to be discovered by accident rather than intentionally through screening, leading Lahey Hospital & Medical Center to develop a high-volume CT lung cancer screening program, which is scanning about 65% of the eligible population with impressive results.

    Dec 9, 2019
  • Sight Diagnostics Receives FDA Clearance For Blood Test Device

    Diagnostics World News | Sight Diagnostics' AI-based blood diagnostics device—called OLO—recently received 510(k) clearance for the US Food and Drug Administration (FDA), allowing the device to be marketed and sold in the US.

    Dec 6, 2019
  • Veracyte Acquires nCounter Platform For Diagnostics

    Diagnostics World News | Veracyte announced today that it has executed a definitive agreement with NanoString for the exclusive global license to the nCounter platform for diagnostic use as well as other tests for $40 million in cash and $10 million in stock.

    Dec 3, 2019
  • Proscia, Vela, Certara, and More: News From November 2019

    Diagnostics World News | November featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Proscia, Vela, Certara, and more.

    Nov 27, 2019
  • Research Unraveling The Mysteries of the Human Placenta

    Diagnostics World News | Researchers recently took a step towards unraveling the "black box" of pregnancy with a new imaging technique called pseudo-continuous arterial spin labeling magnetic resonance imaging (pCASL MRI), which tracks maternal blood flow to the placenta.

    Nov 26, 2019
  • Follow The Money: Investments and Funding Rounds for November

    Diagnostics World News | Some of the latest funding updates from across life sciences, clinical trials, the diagnostics industries.

    Nov 22, 2019
  • Scaling Precision Oncology

    Diagnostics World | Kenna Mills-Shaw believes that precision oncology is neither an illusion nor a panacea. But while there have been some dramatic wins for specific, molecularly-defined tumors, scaling precision oncology will require a highly integrated decision support platform.

    Nov 19, 2019